DEXTROSE MONOHYDRATE injection

Страна: Соединенные Штаты

Язык: английский

Источник: NLM (National Library of Medicine)

Активный ингредиент:

DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK)

Доступна с:

International Medication Systems, Limited

ИНН (Международная Имя):

DEXTROSE MONOHYDRATE

состав:

DEXTROSE MONOHYDRATE 500 mg in 1 mL

Администрация маршрут:

PARENTERAL

Тип рецепта:

PRESCRIPTION DRUG

Терапевтические показания :

50% Dextrose Injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. The solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. Slow infusion of hypertonic solutions is essential to ensure proper utilization of dextrose and avoid production of hyperglycemia. A concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present, nor in the presence of delirium tremens if the patient is already dehydrated. Dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

Обзор продуктов:

50% DEXTROSE INJECTION, USP is supplied in single-dose containers as follows: Ten cartons per package. Syringe Assembly Directions: USE ASEPTIC TECHNIQUE Do not assemble until ready to use. *CAUTION: IMPROPER ENGAGING MAY CAUSE GLASS BREAKAGE AND SUBSEQUENT INJURY. Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]

Статус Авторизация:

unapproved drug other

Характеристики продукта

DEXTROSE MONOHYDRATE- DEXTROSE MONOHYDRATE INJECTION
INTERNATIONAL MEDICATION SYSTEMS, LIMITED
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
50 % DEXTROSE INJECTION, USP
Rx Only
Concentrated Dextrose for Intravenous Administration
NOTE: THIS SOLUTION IS HYPERTONIC − SEE WARNINGS AND PRECAUTIONS.
DESCRIPTION
50% Dextrose Injection, USP is a sterile, nonpyrogenic, hypertonic
solution of dextrose in water for
injection for intravenous injection as a fluid and nutrient
replenisher.
Each mL of fluid contains 0.5 g dextrose, hydrous which delivers 3.4
kcal/gram. The solution has an
osmolarity of 2.5 mOsmol/mL (calc.) and a pH of 3.2-6.5.
The solution contains no bacteriostat, antimicrobial agent or added
buffer and is intended only for use as
a single-dose injection. When smaller doses are required, the unused
portion should be discarded with
the entire unit.
Dextrose, USP is chemically designated C H O • H O (D-glucose
monohydrate), a hexose sugar
freely soluble in water. Dextrose, hydrous has the following formula:
Water for Injection, USP is chemically designated H O.
The delivery device is composed of a 50 mL glass syringe barrel with
rubber stopper, and custom
molded IMS injector with Luer Connector.
CLINICAL PHARMACOLOGY
When administered intravenously this solution restores blood glucose
levels in hypoglycemia and
provides a source of carbohydrate calories.
Carbohydrate in the form of dextrose may aid in minimizing liver
glycogen depletion and exerts a
protein-sparing action. Dextrose injection undergoes oxidation to
carbon dioxide and water.
Water is an essential constituent of all body tissues and accounts for
approximately 70% of total body
weight. Average normal adult requirement ranges from two to three
liters (1.0 to 1.5 liters each for
insensible water loss by perspiration and urine production).
Water balance is maintained by various regulatory mechanis